PMC:7600245 / 37031-37233
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T139 | 184-192 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T336 | 159-161 | http://purl.obolibrary.org/obo/CLO_0053733 | denotes | 11 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T568 | 42-51 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
| T569 | 137-140 | Chemical | denotes | INF | http://purl.obolibrary.org/obo/CHEBI_52999 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T275 | 0-202 | Sentence | denotes | Currently, danoprevir in combination with ritonavir, is being evaluated in two clinical trials (NCT04345276; n = 10) and (with nebulized INF; NCT04291729; n = 11) for the treatment of COVID-19 patients. |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1107 | 193-201 | Species | denotes | patients | Tax:9606 |
| 1113 | 11-21 | Chemical | denotes | danoprevir | MESH:C553752 |
| 1114 | 42-51 | Chemical | denotes | ritonavir | MESH:D019438 |
| 1120 | 184-192 | Disease | denotes | COVID-19 | MESH:C000657245 |